L. Guillevin, The Five-Factor Score Revisited, Medicine, vol.90, issue.1, pp.19-27, 2011.
DOI : 10.1097/MD.0b013e318205a4c6

J. C. Jennette, 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, pp.1-11, 2012.
DOI : 10.1002/art.37715

W. Koldingsnes and H. Nossent, Epidemiology of Wegener's granulomatosis in Northern Norway, Arthritis & Rheumatism, vol.12, issue.11, pp.2481-2488, 2000.
DOI : 10.1002/1529-0131(200011)43:11<2481::AID-ANR15>3.0.CO;2-6

R. A. Watts, The contrasting epidemiology of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis, Rheumatology, vol.51, issue.5, pp.51-926, 2012.
DOI : 10.1093/rheumatology/ker454

E. Reinhold-keller, Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany, Rheumatology, vol.39, issue.12, pp.39-1396, 2000.
DOI : 10.1093/rheumatology/39.12.1396

A. Mahr, Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: A capture-recapture estimate, Arthritis Care & Research, vol.9, issue.Suppl 1, pp.92-101, 2004.
DOI : 10.1002/art.20077

R. A. Watts, Epidemiology of vasculitis in Europe, Annals of the Rheumatic Diseases, vol.60, issue.12, pp.1156-1163, 2001.
DOI : 10.1136/ard.60.12.1156a

K. Aasarod, Wegener's granulomatosis: clinical course in 108 patients with renal involvement, Nephrology Dialysis Transplantation, vol.15, issue.5, pp.611-619, 2000.
DOI : 10.1093/ndt/15.5.611

N. I. Abdou, Wegener's granulomatosis: survey of 701 patients in North America Changes in outcome in the 1990s The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources, J Rheumatol Arthritis Rheum, vol.29, issue.21, pp.309-325, 1996.

L. Guillevin, A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis, Arthritis & Rheumatism, vol.38, issue.12, pp.40-2187, 1997.
DOI : 10.1002/art.1780401213

E. L. Matteson, Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort, The American Journal of Medicine, vol.101, issue.2, pp.129-163, 1996.
DOI : 10.1016/S0002-9343(96)80066-0

L. Guillevin, Rituximab versus azathioprine for maintenance in ANCAassociated vasculitis, N Engl J Med, pp.371-1771, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01116525

D. M. Carruthers, WEGENER'S GRANULOMATOSIS???INCREASED INCIDENCE OR INCREASED RECOGNITION?, Rheumatology, vol.35, issue.2, pp.142-147, 1996.
DOI : 10.1093/rheumatology/35.2.142

S. Bakthavachalam, Hearing Loss in Wegener??s Granulomatosis, Otology & Neurotology, vol.25, issue.5, pp.833-840, 2004.
DOI : 10.1097/00129492-200409000-00030

D. Cruz and D. P. , Ear, nose, and throat symptoms in subacute Wegener's granulomatosis, BMJ, issue.6696, pp.299-419, 1989.

M. B. Gluth, P. A. Shinners, and J. L. Kasperbauer, Subglottic stenosis associated with Wegener's granulomatosis, Laryngoscope, issue.8, pp.113-1304, 2003.

G. S. Hoffman, Wegener Granulomatosis: An Analysis of 158 Patients, Annals of Internal Medicine, vol.116, issue.6, pp.488-98, 1992.
DOI : 10.7326/0003-4819-116-6-488

C. A. Langford, A staged approach to the treatment of Wegener's granulomatosis: Induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance, Arthritis & Rheumatism, vol.72, issue.12, pp.42-2666, 1999.
DOI : 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E

E. Reinhold-keller, No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register, Rheumatology, vol.41, issue.5, pp.540-549, 2002.
DOI : 10.1093/rheumatology/41.5.540

R. Senf, Ruptured arterial aneurysm of the kidney in a patient with Wegener's granulomatosis, Nephrology Dialysis Transplantation, vol.18, issue.12, pp.2671-2674, 2003.
DOI : 10.1093/ndt/gfg380

H. Izzedine, Retroperitoneal fibrosis due to Wegener???s granulomatosis: a misdiagnosis as tuberculosis, The American Journal of Medicine, vol.113, issue.2, pp.164-170, 2002.
DOI : 10.1016/S0002-9343(02)01170-1

D. L. Huong, Urogenital Manifestations of Wegener Granulomatosis, Medicine, vol.74, issue.3, pp.152-61, 1995.
DOI : 10.1097/00005792-199505000-00005

S. Matsuda, A Case of Wegener's Granulomatosis with Necrosis of the Penis, The Tohoku Journal of Experimental Medicine, vol.118, issue.2, pp.145-51, 1976.
DOI : 10.1620/tjem.118.145

K. De-groot, Standardized neurologic evaluations of 128 patients with Wegener granulomatosis Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic, Arch Neurol Ann Neurol, vol.28, issue.331, pp.58-1215, 1993.

E. Reinhold-keller, An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients, Arthritis & Rheumatism, vol.43, issue.5, pp.43-1021, 2000.
DOI : 10.1002/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J

R. W. Hurst and R. I. Grossman, Neuroradiology of Central Nervous System Vasculitis, Seminars in Neurology, vol.14, issue.04, pp.320-360, 1994.
DOI : 10.1055/s-2008-1041092

G. Anderson, Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee, Q J Med, issue.302, pp.83-427, 1992.

S. K. Barksdale, Cutaneous Pathology in Wegener??s Granulomatosis, The American Journal of Surgical Pathology, vol.19, issue.2, pp.161-72, 1995.
DOI : 10.1097/00000478-199502000-00005

Y. Manchanda, Strawberry gingiva: a distinctive sign in wegener's granulomatosis, Journal of the American Academy of Dermatology, vol.49, issue.2, pp.335-342, 2003.
DOI : 10.1067/S0190-9622(03)00556-5

G. L. Jones, Wegener???s granulomatosis mimicking a parotid abscess, The Journal of Laryngology & Otology, vol.119, issue.09, pp.746-755, 2005.
DOI : 10.1258/0022215054797952

J. Z. Forstot, Cardiac complications of wegener granulomatosis: A case report of complete heart block and review of the literature, Seminars in Arthritis and Rheumatism, vol.10, issue.2, pp.148-54, 1980.
DOI : 10.1016/0049-0172(80)90005-0

S. Morelli, Cardiac involvement in patients with Wegener's granulomatosis Wegener's granulomatosis: histological documentation of common and uncommon manifestations in 216 patients, Rheumatol Int Lie, J.T. Vasa, vol.19, issue.264, pp.209-221, 1997.

L. Guillevin, Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients, Arthritis & Rheumatism, vol.337, issue.3, pp.421-451, 1999.
DOI : 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6

A. Serra, Vasculitis affecting the kidney: presentation, histopathology and longterm outcome, Q J Med, vol.53, issue.210, pp.181-207, 1984.

C. O. Savage, Microscopic polyarteritis: presentation, pathology and prognosis, Q J Med, vol.56, issue.220, pp.467-83, 1985.

D. Adu, Polyarteritis and the kidney Histopathologic classification of ANCA-associated glomerulonephritis Pulmonary haemorrhage complicating Wegener's granulomatosis and microscopic polyarteritis, Q J Med J Am Soc Nephrol Br Med J (Clin Res Ed), vol.42, issue.436484, pp.62-221, 1985.

S. Homma, H. Matsushita, and K. Nakata, Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides, Respirology, vol.111, issue.2, pp.190-196, 2004.
DOI : 10.1080/03009749950155643

R. Sable-fourtassou, Antineutrophil Cytoplasmic Antibodies and the Churg???Strauss Syndrome, Annals of Internal Medicine, vol.143, issue.9, pp.632-640, 2005.
DOI : 10.7326/0003-4819-143-9-200511010-00006

J. G. Lanham, Systemic Vasculitis with Asthma and Eosinophilia, Medicine, vol.63, issue.2, pp.65-81, 1984.
DOI : 10.1097/00005792-198403000-00001

R. A. Sinico, Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome, Arthritis & Rheumatism, vol.33, issue.9, pp.2926-2961, 2005.
DOI : 10.1002/art.21250

C. Comarmond, Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort, Arthritis & Rheumatism, vol.97, issue.Suppl 52, pp.270-81, 2013.
DOI : 10.1002/art.37721

URL : https://hal.archives-ouvertes.fr/inserm-00872767

L. Guillevin, Churg-Strauss syndrome Clinical study and long-term follow-up of 96 patients Specks, Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists syndrome: outcome and long-term follow-up of 32 patients, Medicine (Baltimore) Am J Med Rheumatology (Oxford), vol.78, issue.517, pp.26-37, 1999.

M. Y. Kim, Clinical features and prognostic factors of Churg-Strauss syndrome, The Korean Journal of Internal Medicine, vol.29, issue.1, pp.85-95, 2014.
DOI : 10.3904/kjim.2014.29.1.85

L. Guillevin, Systemic necrotizing angiitis with asthma: Causes and precipitating factors in 43 cases, Lung, vol.27, issue.1, pp.165-72, 1987.
DOI : 10.1007/BF02714432

F. Lhote, [Pleural manifestations in periarteritis nodosa, Wegener's disease and systemic lupus erythematosus] The spectrum of eosinophilic infiltration of the gastrointestinal tract and its relationship to other disorders of angiitis and granulomatosis, Ann Med Interne Hum Pathol, vol.143, issue.101, pp.228-260, 1979.

J. Churg and L. Strauss, Allergic granulomatosis, allergic angiitis, and periarteritis nodosa, Am J Pathol, vol.27, issue.2, pp.277-301, 1951.

D. R. Jayne, Severe pulmonary hemorrhage and systemic vasculitis in association with circulating anti-neutrophil cytoplasm antibodies of IgM class only, Clin Nephrol, vol.32, issue.3, pp.101-107, 1989.

G. Bollee, Pauci-immune Crescentic Glomerulonephritis Associated With ANCA of IgA Class, American Journal of Kidney Diseases, vol.53, issue.6, pp.1063-1070, 2009.
DOI : 10.1053/j.ajkd.2008.10.039

E. Brouwer, Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders, Clinical & Experimental Immunology, vol.11, issue.3, pp.379-86, 1991.
DOI : 10.1111/j.1365-2249.1991.tb05647.x

A. H. Mulder, C. A. Stegeman, and C. G. Kallenberg, Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA, Clinical & Experimental Immunology, vol.93, issue.Suppl. 1, pp.227-259, 1995.
DOI : 10.1111/j.1365-2249.1995.tb08343.x

J. Savige, International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA), American Journal of Clinical Pathology, vol.111, issue.4, pp.507-520, 1999.
DOI : 10.1093/ajcp/111.4.507

J. Savige, Addendum to the International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies, American Journal of Clinical Pathology, vol.120, issue.3, pp.312-320, 2003.
DOI : 10.1309/WAEPADW0K4LPUHFN

K. Gisslen, Relationship between anti-neutrophil cytoplasmic antibody determined with conventional binding and the capture assay, and long-term clinical course in vasculitis, Journal of Internal Medicine, vol.57, issue.2, pp.129-164, 2002.
DOI : 10.1016/0140-6736(90)92205-V

A. Radice, Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener???s), Clinical Chemistry and Laboratory Medicine, vol.51, issue.11, pp.51-2141, 2013.
DOI : 10.1515/cclm-2013-0308

E. Csernok and F. Moosig, Current and emerging techniques for ANCA detection in vasculitis, Nature Reviews Rheumatology, vol.30, issue.8, pp.494-501, 2014.
DOI : 10.1186/ar4119

E. C. Hagen, Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis, Kidney International, vol.53, issue.3, pp.743-53, 1998.
DOI : 10.1046/j.1523-1755.1998.00807.x

A. Radice, L. Bianchi, and R. A. Sinico, Anti-neutrophil cytoplasmic autoantibodies: Methodological aspects and clinical significance in systemic vasculitis, Autoimmunity Reviews, vol.12, issue.4, pp.487-95, 2013.
DOI : 10.1016/j.autrev.2012.08.008

R. Y. Leavitt, The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis, Arthritis & Rheumatism, vol.19, issue.8, pp.1101-1108, 1990.
DOI : 10.1002/art.1780330807

A. T. Masi, The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis), Arthritis & Rheumatism, vol.56, issue.8
DOI : 10.1002/art.1780330806

J. C. Jennette, Nomenclature of Systemic Vasculitides, Arthritis & Rheumatism, vol.91, issue.2, pp.187-92, 1994.
DOI : 10.1002/art.1780370206

S. Lionaki, Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis, Arthritis & Rheumatism, vol.111, issue.10, pp.64-3452, 2012.
DOI : 10.1002/art.34562

M. Samson, Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg???Strauss syndrome) enrolled in two prospective trials, Journal of Autoimmunity, vol.43, issue.43, pp.60-69, 2013.
DOI : 10.1016/j.jaut.2013.03.003

URL : https://hal.archives-ouvertes.fr/hal-00873378

G. S. Kerr, Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with wegener's granulomatosis, Arthritis & Rheumatism, vol.52, issue.3, pp.365-71, 1993.
DOI : 10.1002/art.1780360312

E. Pettersson and Z. Heigl, Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: a longitudinal study, Clin Nephrol, vol.37, issue.5, pp.219-247, 1992.

J. D. Finkielman, Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis, Annals of Internal Medicine, vol.147, issue.9, pp.611-620, 2007.
DOI : 10.7326/0003-4819-147-9-200711060-00005

W. K. Han, Serial ANCA titers: Useful tool for prevention of relapses in ANCA-associated vasculitis, Kidney International, vol.63, issue.3, pp.1079-85, 2003.
DOI : 10.1046/j.1523-1755.2003.00821.x

J. Damoiseaux, A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis Association between active Wegener's granulomatosis and anticytoplasmic antibodies, Ann Rheum Dis Arch Intern Med, vol.68, issue.211, pp.149-2461, 1989.

D. R. Jayne, ANCA and predicting relapse in systemic vasculitis Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides ANCA titres, even of IgG subclasses, and soluble CD14 fail to predict relapses in patients with ANCA-associated vasculitis, QJM Arthritis Rheum Ann Rheum Dis Nephrol Dial Transplant, vol.88, issue.838, pp.127-160, 1995.

J. S. Sanders, Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment, Rheumatology, vol.45, issue.6, pp.45-724, 2006.
DOI : 10.1093/rheumatology/kei272

T. Girard, Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study, Rheumatology, vol.40, issue.2, pp.147-51, 2001.
DOI : 10.1093/rheumatology/40.2.147

G. Gaskin, Anti-neutrophil Cytoplasmic Antibodies and Disease Activity During Long-Term Follow-up of 70 Patients with Systemic Vasculitis, Nephrology Dialysis Transplantation, vol.6, issue.10, pp.689-94, 1991.
DOI : 10.1093/ndt/6.10.689

C. A. Stegeman, Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis, Annals of Internal Medicine, vol.120, issue.1, pp.12-19, 1994.
DOI : 10.7326/0003-4819-120-1-199401010-00003

X. Kyndt, Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis, The American Journal of Medicine, vol.106, issue.5, pp.527-560, 1999.
DOI : 10.1016/S0002-9343(99)00064-9

G. Tomasson, Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis, Rheumatology, vol.51, issue.1, pp.100-109, 2012.
DOI : 10.1093/rheumatology/ker280

P. J. Bansal and M. C. Tobin, Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase???antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement, Annals of Allergy, Asthma & Immunology, vol.93, issue.4, pp.398-401, 2004.
DOI : 10.1016/S1081-1206(10)61400-7

H. Xiao, Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice, Journal of Clinical Investigation, vol.110, issue.7, pp.955-63, 2002.
DOI : 10.1172/JCI0215918

M. A. Little, Anti-proteinase 3 anti-neutrophil cytoplasm autoantibodies recapitulate systemic vasculitis in mice with a humanized immune system [Pathophysiology of ANCA-associated vasculitides], PLoS One Presse Med, vol.7, issue.110, pp.41-996, 2012.

C. G. Kallenberg, Pathogenesis of PR3-ANCA associated vasculitis, Journal of Autoimmunity, vol.30, issue.1-2, pp.29-36, 2008.
DOI : 10.1016/j.jaut.2007.11.005

C. G. Kallenberg, Advances in pathogenesis and treatment of ANCA-associated vasculitis, Discov Med, vol.18, issue.99, pp.195-201, 2014.

E. F. Mckinney, The immunopathology of ANCA-associated vasculitis, Seminars in Immunopathology, vol.121, issue.4, pp.461-78, 2014.
DOI : 10.1007/s00281-014-0436-6

W. F. Pendergraft, Autoimmunity is triggered by cPR-3(105???201), a protein complementary to human autoantigen proteinase-3, Nature Medicine, vol.10, issue.1, pp.72-81, 2004.
DOI : 10.1038/nm968

H. Tadema, Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitis High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis, PLoS One J Am Soc Nephrol, vol.6, issue.233, pp.556-66, 2011.

R. Kain, Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis, Nature Medicine, vol.102, issue.10, pp.1088-96, 2008.
DOI : 10.1038/nm.1874

A. J. Roth, Anti-LAMP-2 Antibodies Are Not Prevalent in Patients With Antineutrophil Cytoplasmic Autoantibody Glomerulonephritis, Journal of the American Society of Nephrology, vol.23, issue.3, pp.545-55, 2012.
DOI : 10.1681/ASN.2011030273

H. Xiao, Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies, The American Journal of Pathology, vol.170, issue.1, pp.52-64, 2007.
DOI : 10.2353/ajpath.2007.060573

D. Huugen, Inhibition of complement factor C5 protects against antimyeloperoxidase antibody-mediated glomerulonephritis in mice, Kidney Int, issue.7, pp.71-646, 2007.

V. Witko-sarsat, N. Reuter, and L. Mouthon, Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener??s granulomatosis, Current Opinion in Rheumatology, vol.22, issue.1, pp.1-7, 2010.
DOI : 10.1097/BOR.0b013e3283331594

P. A. Lyons, Genetically Distinct Subsets within ANCA-Associated Vasculitis, New England Journal of Medicine, vol.367, issue.3, pp.214-237, 2012.
DOI : 10.1056/NEJMoa1108735

J. S. Mclaren, The diagnostic value of anti-neutrophil cytoplasmic antibody testing in a routine clinical setting, QJM, vol.94, issue.11, pp.94-615, 2001.
DOI : 10.1093/qjmed/94.11.615

J. H. Stone, Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions, Arthritis & Rheumatism, vol.87, issue.6, pp.424-458, 2000.
DOI : 10.1002/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q

K. Tsiveriotis, Antineutrophil Cytoplasmic Antibodies Testing in a Large Cohort of Unselected Greek Patients, Autoimmune Diseases, vol.111, issue.4, p.626495, 2011.
DOI : 10.1016/j.cca.2008.07.026

R. Cartin-ceba, Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center, Arthritis & Rheumatism, vol.39, issue.11, pp.64-3770, 2012.
DOI : 10.1002/art.34584